Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom

2

By Manya Saini and Niket Nishant Oct 8 (Reuters) – Nvidia-backed Iambic Therapeutics, which uses AI to develop drugs, is aiming to raise up to $159.4 million in its US IPO, as the biotech sector

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)